Myomo Reports Fourth Quarter and Full Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Myomo (MYO) Tops Q4 EPS by 12c, Revenues Beat
March 10, 2021 4:14 PM ESTMyomo (NYSE: MYO) reported Q4 EPS of ($0.37), $0.12 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $3.02 million.
Revenue was up 149% to a record $3.8 million101 units were delivered to patients including 97 recognized as revenue, a 126% increaseRevenue from the direct billing channel represented 77% of total revenue, up from 68% of revenue in the... More